Porous scaffolds support bone repair by creating an osteoconductive framework, meaning a surface and structure that can support cell attachment and tissue ingrowth. Their architecture helps new tissue occupy the defect, while the scaffold’s material properties influence how effectively this process occurs. This makes porosity a functional design feature rather than merely a physical characteristic.
Some biologic materials may contribute signals that promote osteogenic activity, supporting bone-forming processes at the repair site. This differs from a scaffold’s primarily structural contribution: one supplies signaling potential, while the other provides an environment for attachment and ingrowth. Considering both functions helps explain why alternatives can be designed around different mechanisms.
Gradual resorption can allow a temporary material to be replaced by new bone, rather than leaving the scaffold as the final structure. The desired balance depends on material properties and the defect environment: resorption must support the repair process while new tissue develops. This relationship links scaffold persistence with the timing of regeneration.
Bone graft alternatives become particularly relevant when an autograft or donor bone is unavailable, insufficient, or undesirable. They may expand treatment options while reducing donor-site complications associated with obtaining tissue from the patient. However, their suitability still depends on the defect, vascularization, material behavior, and the patient’s capacity for bone regeneration.
Performance depends on several interacting conditions, including the material’s properties, the size and characteristics of the defect, the availability of vascularization, and the patient’s capacity for bone regeneration. These factors affect cell attachment, tissue ingrowth, signaling, and replacement by new bone, so the same alternative may not perform identically in every clinical setting.
Bone graft alternatives are applied across several areas of medicine, including fracture healing, spinal fusion, dental reconstruction, and orthopedic implant procedures. These settings may require structural support, biologic stimulation, or gradual replacement by new bone. Their broad use reflects the need for options when conventional autograft or donor bone cannot meet clinical requirements.
Evaluation can focus on whether the material supports cell attachment, tissue ingrowth, osteogenic activity, and eventual replacement by new bone. Clinicians must also consider the condition of the defect, vascularization, and the patient’s regenerative capacity. Together, these outcomes indicate whether the alternative is providing appropriate support for the intended repair or reconstruction.